🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, open-label, single-arm phase II clinical trial...
Status
Recruiting
Location
First Affiliated Hospital of Nanjing Medical Unviersity
Start Date
2024-11-14
Trial ID
NCT06895447
Treatments Being Tested
Evaluation of detection rate of 18F-Fluciclovine compared to current standa...
Status
Completed
Location
John Cochran VA Medical Center St. Louis
Start Date
2018-12-18
Trial ID
NCT03527199
Treatments Being Tested
The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Status
Recruiting
Location
Cedars-Sinai Women's Heart Center
Start Date
2015-10
Trial ID
NCT02582021
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
This randomized phase III trial studies how well pazopanib hydrochloride wo...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2012-08-08
Trial ID
NCT01575548
The purpose of this study is to assess whether NaF PET/CT scans can be used...
Status
Terminated
Location
University of Wisconsin Carbone Cancer Center
Start Date
2013-05
Trial ID
NCT01816048
Treatments Being Tested
This study aims to investigate the pathophysiology of recurrent pericarditi...
Status
Unknown
Location
Saarland University
Start Date
2023-07-01
Trial ID
NCT05925790
Treatments Being Tested
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare condition ...
Status
Unknown
Location
Aberdeen Royal Infirmary
Start Date
2015-08
Trial ID
NCT02989480
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713